Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-01-14

Clinical Trial Update: Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colon Cancer That Cannot Be Removed By Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating combination chemotherapy with bevacizumab in stage IV colorectal cancer unsuitable for surgical resection, completed with posted result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bevacizumab (bevacizumab)

Snippet

Sponsor: NSABP Foundation Inc | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-01-14